Remove 2002 Remove Communication Remove Pharmaceutical Companies
article thumbnail

Cheryl Barton

pharmaphorum

Following her senior research positions in academia and seven years with Merck & Co, she joined Dutch investment bank ABN Amro NV as a senior equity analyst to provide coverage on pan-European companies.

article thumbnail

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

article thumbnail

Holistic immunology: Supporting patients at every stage of their journey

pharmaphorum

Max Pahlow is vice president & regional commercial strategy leader (EMEA) of immunology & CVM (cardiovascular & metabolism) for the Janssen pharmaceutical companies of Johnson & Johnson. The post Holistic immunology: Supporting patients at every stage of their journey appeared first on.

Immunity 105